Diabetes, insulin therapy, and colorectal cancer: Evidence indicates a modest increase in risk of bowel cancer among people with type 2 diabetes
AUTOR(ES)
Renehan, Andrew G
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=554015Documentos Relacionados
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- Type 2 diabetes, thiazolidinediones, and cardiovascular risk
- Chronic subclinical bowel inflammation may explain increased risk of colorectal cancer in obese people
- Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians
- Selenium supplements may increase risk of type 2 diabetes